Introduction: The impact of several dementia syndromes on activities of daily living (ADLs) has been well documented, but no study has yet investigated functional ability in posterior cortical atrophy (PCA). The primarily visual nature of deficits in this condition is likely to have a pronounced impact on ADLs. Objective: The aim of this study was to profile functional change in PCA and identify predictors of change. Method: Twenty-nine PCA patients and 25 patients with typical Alzheimer’s disease (AD) and their caregivers were included in this cross-sectional study. ADLs were assessed using the Disability Assessment for Dementia (DAD), administered to caregivers, assessing basic ADLs (e.g., eating, dressing) and instrumental ADLs (e.g., managing finances, meal preparation). The predictive utility of cognitive domains (Addenbrooke’s Cognitive Examination), behavioural impairment (Cambridge Behavioural Inventory-Revised) and demographic variables on ADL ability was also examined. Results: PCA patients showed significantly reduced total ADL scores compared to AD patients (medium effect size, d = –0.7; p < 0.05), with significantly more impairment on basic ADLs (large effect size, d = –0.8; p < 0.05) but similar impairment on instrumental ADLs (medium effect size, d = –0.5; p > 0.05). A model combining patient mood, disinhibition, apathy, symptom duration, and memory and attention/orientation scores explained the variance of scores in functional decline (61.2%), but the key factor predicting ADL scores was attention/orientation (p = 0.048). Conclusion: This study shows the profound impact of PCA on ADLs and factors underpinning patients’ disability. Attention/orientation deficits were found to correlate and contribute to variance in ADL scores. Future work to develop tailored interventions to manage ADL impairment in PCA should take these findings into account.

1.
Crutch
SJ
,
Schott
JM
,
Rabinovici
GD
,
Murray
M
,
Snowden
JS
,
van der Flier
WM
, et al.;
Alzheimer’s Association ISTAART Atypical Alzheimer’s Disease and Associated Syndromes Professional Interest Area
.
Consensus classification of posterior cortical atrophy
.
Alzheimers Dement
.
2017
Aug
;
13
(
8
):
870
84
.
[PubMed]
1552-5260
2.
McMonagle
P
,
Deering
F
,
Berliner
Y
,
Kertesz
A
.
The cognitive profile of posterior cortical atrophy
.
Neurology
.
2006
Feb
;
66
(
3
):
331
8
.
[PubMed]
0028-3878
3.
Tang-Wai
DF
,
Graff-Radford
NR
,
Boeve
BF
,
Dickson
DW
,
Parisi
JE
,
Crook
R
, et al.
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
.
Neurology
.
2004
Oct
;
63
(
7
):
1168
74
.
[PubMed]
0028-3878
4.
Mioshi
E
,
Kipps
CM
,
Dawson
K
,
Mitchell
J
,
Graham
A
,
Hodges
JR
.
Activities of daily living in frontotemporal dementia and Alzheimer disease
.
Neurology
.
2007
Jun
;
68
(
24
):
2077
84
.
[PubMed]
0028-3878
5.
O’Connor
CM
,
Landin-Romero
R
,
Clemson
L
,
Kaizik
C
,
Daveson
N
,
Hodges
JR
, et al.
Behavioral-variant frontotemporal dementia: distinct phenotypes with unique functional profiles
.
Neurology
.
2017
Aug
;
89
(
6
):
570
7
.
[PubMed]
0028-3878
6.
Jang
J
,
Cushing
N
,
Clemson
L
,
Hodges
JR
,
Mioshi
E
.
Activities of daily living in progressive non-fluent aphasia, logopenic progressive aphasia and Alzheimer’s disease
.
Dement Geriatr Cogn Disord
.
2012
;
33
(
5
):
354
60
.
[PubMed]
1420-8008
7.
O’Connor
CM
,
Clemson
L
,
Hornberger
M
,
Leyton
CE
,
Hodges
JR
,
Piguet
O
, et al.
Longitudinal change in everyday function and behavioral symptoms in frontotemporal dementia
.
Neurol Clin Pract
.
2016
Oct
;
6
(
5
):
419
28
.
[PubMed]
2163-0402
8.
O’Connor
C
,
Ahmed
S
,
Mioshi
E
.
Functional disability in primary progressive aphasia
.
Aphasiology
.
2014
;
28
(
8-9
):
1131
49
. 0268-7038
9.
Lawton
MP
,
Brody
EM
.
Assessment of older people: self-maintaining and instrumental activities of daily living
.
Gerontologist
.
1969
;
9
(
3
):
179
86
.
[PubMed]
0016-9013
10.
Shakespeare
TJ
,
Yong
KX
,
Foxe
D
,
Hodges
J
,
Crutch
SJ
.
Pronounced impairment of everyday skills and self-care in posterior cortical atrophy
.
J Alzheimers Dis
.
2015
;
43
(
2
):
381
4
.
[PubMed]
1387-2877
11.
Bier
N
,
El-Samra
A
,
Bottari
C
,
Vallet
GT
,
Carignan
M
,
Pagnette
G
, et al.
Posterior cortical atrophy: impact on daily living activitise and exploration of a cognitive rehabilitation approach
.
Cogent Psychol
.
2019
;
6
(
1
). 2331-1908
12.
Weill-Chounlamountry
A
,
Poncet
E
,
Crop
S
,
Hesly
N
,
Pradat-Diehl
P
.
Multidisciplinary rehabiliatation in a case of posterior cortical atrophy
.
Ann Phys Rehabil Med
.
2012
;
55
s1
. 1877-0657
13.
McKhann
G
,
Drachman
D
,
Folstein
M
,
Katzman
R
,
Price
D
,
Stadlan
EM
.
Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease
.
Neurology
.
1984
Jul
;
34
(
7
):
939
44
.
[PubMed]
0028-3878
14.
McKhann
GM
,
Knopman
DS
,
Chertkow
H
,
Hyman
BT
,
Jack
CR
 Jr
,
Kawas
CH
, et al.
The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
.
Alzheimers Dement
.
2011
May
;
7
(
3
):
263
9
.
[PubMed]
1552-5260
15.
Cushing
N
,
Jang
J
,
O’Connor
CM
,
Burrell
JR
,
Clemson
L
,
Hodges
JR
, et al.
Disability in atypical parkinsonian syndromes is more dependent on memory dysfunction than motor symptoms
.
Parkinsonism Relat Disord
.
2013
Apr
;
19
(
4
):
436
40
.
[PubMed]
1353-8020
16.
Hsieh
S
,
Schubert
S
,
Hoon
C
,
Mioshi
E
,
Hodges
JR
.
Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease
.
Dement Geriatr Cogn Disord
.
2013
;
36
(
3-4
):
242
50
.
[PubMed]
1420-8008
17.
Wedderburn
C
,
Wear
H
,
Brown
J
,
Mason
SJ
,
Barker
RA
,
Hodges
J
, et al.
The utility of the Cambridge Behavioural Inventory in neurodegenerative disease
.
J Neurol Neurosurg Psychiatry
.
2008
May
;
79
(
5
):
500
3
.
[PubMed]
0022-3050
18.
Cohen
J
.
Statistical power analysis for the behavioural sciences
.
Routledge
;
1977
.
19.
Ahmed
S
,
Baker
I
,
Husain
M
,
Thompson
S
,
Kipps
C
,
Hornberger
M
, et al.
Memory Impairment at Initial Clinical Presentation in Posterior Cortical Atrophy
.
J Alzheimers Dis
.
2016
Apr
;
52
(
4
):
1245
50
.
[PubMed]
1387-2877
20.
Ahmed
S
,
Irish
M
,
Loane
C
,
Baker
I
,
Husain
M
,
Thompson
S
, et al.
Association between precuneus volume and autobiographical memory impairment in posterior cortical atrophy: beyond the visual syndrome
.
Neuroimage Clin
.
2018
Mar
;
18
:
822
34
.
[PubMed]
2213-1582
21.
Ahmed
S
,
Loane
C
,
Bartels
S
,
Zamboni
G
,
Mackay
C
,
Baker
I
, et al.
Lateral parietal contributions to memory impairment in posterior cortical atrophy
.
Neuroimage Clin
.
2018
Jul
;
20
:
252
9
.
[PubMed]
2213-1582
22.
Enache
D
,
Winblad
B
,
Aarsland
D
.
Depression in dementia: epidemiology, mechanisms, and treatment
.
Curr Opin Psychiatry
.
2011
Nov
;
24
(
6
):
461
72
.
[PubMed]
0951-7367
23.
Husain
M
,
Roiser
JP
.
Neuroscience of apathy and anhedonia: a transdiagnostic approach
.
Nat Rev Neurosci
.
2018
Aug
;
19
(
8
):
470
84
.
[PubMed]
1471-003X
24.
Boyle
PA
,
Malloy
PF
,
Salloway
S
,
Cahn-Weiner
DA
,
Cohen
R
,
Cummings
JL
.
Executive dysfunction and apathy predict functional impairment in Alzheimer disease
.
Am J Geriatr Psychiatry
.
2003
Mar-Apr
;
11
(
2
):
214
21
.
[PubMed]
1064-7481
25.
Brodaty
H
,
Burns
K
.
Nonpharmacological management of apathy in dementia: a systematic review
.
Am J Geriatr Psychiatry
.
2012
Jul
;
20
(
7
):
549
64
.
[PubMed]
1064-7481
26.
Renner
JA
,
Burns
JM
,
Hou
CE
,
McKeel
DW
 Jr
,
Storandt
M
,
Morris
JC
.
Progressive posterior cortical dysfunction: a clinicopathologic series
.
Neurology
.
2004
Oct
;
63
(
7
):
1175
80
.
[PubMed]
0028-3878
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.